Retraction
MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells
Paper Information
Record ID:
25661
Author(s):
Journal:
Publication Date:
July 05, 2019
Retraction Date:
January 27, 2021
(4.8 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Royal Society of Chemistry (RSC)
Open Access:
Yes
DOI:
PubMed ID:
Not indexed in PubMed
Retraction PubMed ID:
Not indexed in PubMed
Retraction Details
Citations (0)
0
Total Citations0
Post-Retraction0
Pre-Retraction0
Same Day
No citations found for this paper.
Quick Stats
Total Citations:
0
Years Since Retraction:
4.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025